Filing Details

Accession Number:
0000899243-18-014656
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-06-01 14:37:21
Reporting Period:
2018-05-29
Accepted Time:
2018-06-01 14:37:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1537917 Tyme Technologies Inc. TYME Pharmaceutical Preparations (2834) 453864597
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1712467 Michael Demurjian C/O Tyme Technologies, Inc.
17 State Street - 7Th Floor
New York NY 10004
Chief Operating Officer Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-05-29 8,382 $3.75 26,669,754 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 9, 2018.